Remove 2006 Remove Labelling Remove Vaccines
article thumbnail

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmaTech

Thakar Varanya Chaiyaperm View All News Article Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Part two discussion describes a simple medication order and demonstrates calculations and labeling for each bulk drug type. Pluta Nishant B. Mole calculations.

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

FAP-2286 (labeled with lutetium-177), a peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting fibroblast activation protein (FAP), is the company’s lead asset amongst radiopharma products. In 2021, Telix generated total revenue of $7.59M from the sales of its radiopharma products.

Dosage 56
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B in the year 2006, thereby depicting a growth rate of 5.6%. in revenue following the addition of Pfizer’s consumer health business in the year 2006. in revenue following the addition of Pfizer’s consumer health business in the year 2006.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

Robert Wood’s granddaughter, Mary Lea, was the first baby to be used on the baby powder label. In 2006, J&J acquired Pfizer Consumer Healthcare for $16.6 Johnson’s Baby Powder also went on sale during this year and was extremely successful. billion in cash.

Vaccines 126